Botox Maker Offers Up To $375M For Fellow Skin Care Co.
Under the deal's terms, Allergan will pay $350 million up front and make a follow-up payment of $25 million if SkinMedica's products hit certain sales targets. Through the transaction, Allergan would lift SkinMedica ownership from nearly a dozen investment firms including Apax Partners LLP and BlueCrest Capital Management LLP.
In the sale,...
To view the full article, register now.